XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Incentive Plans
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
The following table is a summary of the Company’s stock options outstanding as of June 30, 2022, and changes therein during the six months then ended.
 Number of Stock OptionsWeighted Average Grant Date Fair ValueWeighted Average Exercise PriceWeighted Average Contractual Life (years)
Outstanding - December 31, 20211,769,979 $4.02 $13.95 2.95
Exercised(17,040)3.95 13.54 — 
Outstanding - June 30, 20221,752,939 4.02 13.96 2.46
Exercisable - June 30, 20221,752,939 4.02 13.96 2.46
 On January 28, 2022, the Company granted to directors and employees, under the 2019 Equity Incentive Plan, 157,416 restricted stock awards with a total grant-date fair value of $2.5 million. Of these grants, 30,798 vest one year from the date of grant and 126,618 vest in equal installments over a three-year period beginning one year from the date of grant. The Company also issued 24,492 performance-based restricted stock units to its executive officers with a total grant date fair value of $386,484. Vesting of the performance-based restricted stock units will be based on achievement of certain levels of Core Return on Average Assets and will cliff-vest after a three-year measurement period ended December 31, 2024. At the end of the performance period, the number of actual shares to be awarded may vary between 0% and 120% of target amounts.

The following is a summary of the status of the Company’s restricted stock awards and performance-based restricted stock units at June 30, 2022, and changes therein during the six months then ended.
 Number of Shares AwardedWeighted Average Grant Date Fair Value
Non-vested at December 31, 2021222,844 $13.21 
Granted181,908 15.78 
Vested(62,836)12.87 
Forfeited(16,613)14.28 
Non-vested at June 30, 2022325,303 14.66 
 
Expected future stock award expense related to the non-vested restricted share awards and performance-based restricted stock units as of June 30, 2022, was $3.7 million over a weighted average period of 2.6 years.
During the three months ended June 30, 2022 and June 30, 2021, the Company recorded $449,000 and $261,000, respectively, of stock-based compensation related to the above plan. During the six months ended June 30, 2022 and June 30, 2021, the Company recorded $845,000 and $504,000, respectively, of stock-based compensation related to the above plan.